NZ Lymphoma / Leukaemia Research Review Issue 43

In this issue:

Leukaemia selection
Ivosidenib in IDH1-mutated relapsed/refractory AML
Haploidentical vs. matched sibling donor SCT in AML in first CR
Lymphoma selection
Salvage brentuximab vedotin in Hodgkin’s lymphoma
Prognostic model for hightumour-burden follicular lymphoma
Salvage brentuximab vedotin + bendamustine in relapsed/refractory Hodgkin’s lymphoma
Simple scoring system for de novo follicular lymphoma
Loss of life expectancy in a population-based DLBCL cohort
Bendamustine + rituximab for relapsed/refractory DLBCL
First-line R-GemOx in elderly DLBCL
Molecular subtypes of DLBCL

Please login below to download this issue (PDF)